Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension

被引:196
作者
Holla, VR
Adas, F
Imig, JD
Zhao, XY
Price, E
Olsen, N
Kovacs, WJ
Magnuson, MA
Keeney, DS
Breyer, MD
Falck, JR
Waterman, MR
Capdevila, JH [1 ]
机构
[1] Vanderbilt Univ, Dept Med, Sch Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Dept Mol Physiol, Sch Med, Nashville, TN 37232 USA
[4] Tulane Univ, Sch Med, Dept Physiol, New Orleans, LA 70112 USA
[5] Univ Texas, Hlth Sci Ctr, SW Med Sch, Dept Biochem, Dallas, TX 75235 USA
关键词
D O I
10.1073/pnas.081627898
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hypertension is a leading cause of cardiovascular, cerebral, and renal disease morbidity and mortality. Here we show that disruption of the Cyp 4a14 gene causes hypertension, which is, like most human hypertension, more severe in males. Male Cyp 4a14 (-/-) mice show increases in plasma androgens, kidney Cyp 4a12 expression. and the formation of prohypertensive 20-hydroxyarachidonate. Castration normalizes the blood pressure of Cyp 4a14 (-/-) mice and minimizes Cyp 4a12 expression and arachidonate omega -hydroxylation, Androgen replacement restores hypertensive phenotype, Cyp 4a12 expression, and 20-hydroxy-arachidonate formation. We conclude that the androgen-mediated regulation of Cyp 4a arachidonate monooxygenases is an important component of the renal mechanisms that control systemic blood pressures. These results provide direct evidence for a role of Cyp 4a isoforms in cardiovascular physiology. establish Cyp 4a14 (-/-) mice as a monogenic: model for the study of cause/effect relationships between blood pressure, sex hormones, and P450 omega -hydroxylases, and suggest the human CYP 4A homologues as candidate genes for the analysis of the genetic and molecular basis of human hypertension.
引用
收藏
页码:5211 / 5216
页数:6
相关论文
共 33 条
  • [1] Hypertension in men
    August, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) : 3451 - 3454
  • [2] Capdevila JH, 2000, J LIPID RES, V41, P163
  • [3] CAPDEVILA JH, 1990, METHOD ENZYMOL, V187, P385
  • [4] Chen Y F, 1996, Curr Opin Nephrol Hypertens, V5, P181, DOI 10.1097/00041552-199603000-00015
  • [5] SEXUAL DIMORPHISM OF BLOOD-PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RATS IS ANDROGEN DEPENDENT
    CHEN, YF
    MENG, QC
    [J]. LIFE SCIENCES, 1991, 48 (01) : 85 - 96
  • [6] The role of the kidney in hypertension
    Cowley, AW
    Roman, RJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (20): : 1581 - 1589
  • [7] Genes and hypertension - From gene mapping in experimental models to vascular gene transfer strategies
    Dominiczak, AF
    Negrin, DC
    Clark, JS
    Brosnan, MJ
    McBride, MW
    Alexander, MY
    [J]. HYPERTENSION, 2000, 35 (01) : 164 - 172
  • [8] GANTEN U, 1989, J HYPERTENS, V7, P721
  • [9] The molecular basis of hypertension
    Garbers, DL
    Dubois, SK
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 : 127 - 155
  • [10] Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue
    Harder, DR
    Lange, AR
    Gebremedhin, D
    Birks, EK
    Roman, RJ
    [J]. JOURNAL OF VASCULAR RESEARCH, 1997, 34 (03) : 237 - 243